natgillin/translations-raw huggingface dataset:
(c) Name and identity of the living modified organism, as well as the domestic classification, if any, of the biosafety level of the living modified organism in the State of export.
(c) ime in identiteta živega spremenjenega organizma ter razvrstitev, če obstaja, ravni biološke varnosti tega organizma v državi izvoznici
(d) Intended date or dates of the transboundary movement, if known.
(d) načrtovani datum ali datumi čezmejnega gibanja, če so znani
(e) Taxonomic status, common name, point of collection or acquisition, and characteristics of recipient organism or parental organisms related to biosafety.
(e) sistematska uvrstitev in domače ime prejemnega ali starševskih organizmov, kraj, kjer so bili nabrani ali pridobljeni, in njihove značilnosti, povezane z biološko varnostjo
(f) Centres of origin and centres of genetic diversity, if known, of the recipient organism and/or the parental organisms and a description of the habitats where the organisms may persist or proliferate.
(f) središča izvora in središča genske raznovrstnosti, če so znana, prejemnega organizma in/ali starševskih organizmov in opis habitatov, v katerih bi organizmi lahko obstali ali se razmnoževali
(g) Taxonomic status, common name, point of collection or acquisition, and characteristics of the donor organism or organisms related to biosafety.
(g) sistematska uvrstitev in domače ime organizma ali organizmov dajalcev, kraj, kjer so bili nabrani ali pridobljeni, in njihove značilnosti, povezane z biološko varnostjo
(h) Description of the nucleic acid or the modification introduced, the technique used, and the resulting characteristics of the living modified organism.
(h) opis nukleinske kisline ali vnesene spremembe, uporabljene tehnike in tako nastale značilnosti živega spremenjenega organizma
(i) Intended use of the living modified organism or products thereof, namely, processed materials that are of living modified organism origin, containing detectable novel combinations of replicable genetic material obtained through the use of modern biotechnology.
(i) namen uporabe živega spremenjenega organizma ali izdelkov iz njega (predelani material, ki izvira iz živih spremenjenih organizmov), ki vsebujejo zaznavne nove kombinacije genskega materiala, ki se lahko podvaja in je bil pridobljen z uporabo sodobne biotehnologije
(j) Quantity or volume of the living modified organism to be transferred.
(j) število ali količina živih spremenjenih organizmov, ki bodo preneseni
(k) A previous and existing risk assessment report consistent with Annex III.
(k) prejšnje in zadnje poročilo o izdelani oceni tveganja, skladno s prilogo III
(l) Suggested methods for the safe handling, storage, transport and use, including packaging, labelling, documentation, disposal and contingency procedures, where appropriate.
(l) predlagane metode za varno shranjevanje, prevoz in uporabo živih spremenjenih organizmov ter ravnanje z njimi skupaj s pakiranjem, označevanjem, dokumentiranjem, odstranjevanjem in postopki za ravnanje v posebnih razmerah, če je to primerno
(m) Regulatory status of the living modified organism within the State of export (for example, whether it is prohibited in the State of export, whether there are other restrictions, or whether it has been approved for general release) and, if the living modified organism is banned in the State of export, the reason or reasons for the ban.
(m) s predpisi urejen status živega spremenjenega organizma v državi izvoznici (na primer ali je v državi izvoznici prepovedan, ali zanj veljajo druge omejitve, ali je bilo njegovo sproščanje odobreno) in če je v državi izvoznici ta organizem prepovedan, razlog ali razloge za prepoved
(n) Result and purpose of any notification by the exporter to other States regarding the living modified organism to be transferred.
(n) izid in namen obvestil izvoznika drugim državam o živem spremenjenem organizmu, ki bo prenesen
(o) A declaration that the above-mentioned information is factually correct.
(o) izjava, da so zgoraj navedene informacije točne.
Information Required Concerning Living Modified Organisms Intended for Direct Use as Food or Feed, or for Processing under Article 11
Informacije o živih spremenjenih organizmih, namenjenih za neposredno uporabo kot hrana ali krma ali pa za predelavo, ki so potrebne skladno z 11. členom
(a) The name and contact details of the applicant for a decision for domestic use.
(a) ime in drugi podatki, potrebni za navezavo stikov, o prosilcu za odločitev o domači uporabi
(b) The name and contact details of the authority responsible for the decision.
(b) ime in drugi podatki, potrebni za navezavo stikov, o organu, pristojnem za odločitev
(c) Name and identity of the living modified organism.
(c) ime in identiteta živega spremenjenega organizma
(d) Description of the gene modification, the technique used, and the resulting characteristics of the living modified organism.
(d) opis genske spremembe, uporabljene tehnike in tako nastalih značilnosti živega spremenjenega organizma
(e) Any unique identification of the living modified organism.
(e) identifikacijska oznaka živega spremenjenega organizma
(f) Taxonomic status, common name, point of collection or acquisition, and characteristics of recipient organism or parental organisms related to biosafety.
(f) sistematska uvrstitev in domače ime prejemnega ali starševskih organizmov, kraj, kjer so bili nabrani ali pridobljeni, in njihove značilnosti, povezane z biološko varnostjo
(g) Centres of origin and centres of genetic diversity, if known, of the recipient organism and/or the parental organisms and a description of the habitats where the organisms may persist or proliferate.
(g) središča izvora in središča genske raznovrstnosti, če so znana, prejemnega organizma in/ali starševskih organizmov in opis habitatov, v katerih bi organizmi lahko obstali ali se razmnoževali
(h) Taxonomic status, common name, point of collection or acquisition, and characteristics of the donor organism or organisms related to biosafety.
(h) sistematska uvrstitev in domače ime organizma ali organizmov dajalcev, kraj, kjer so bili nabrani ali pridobljeni, in njihove značilnosti, povezane z biološko varnostjo
(i) Approved uses of the living modified organism.
(i) odobreni načini uporabe živih spremenjenih organizmov
(j) A risk assessment report consistent with Annex III.
(j) poročilo o izdelani oceni tveganja, skladno s prilogo III
(k) Suggested methods for the safe handling, storage, transport and use, including packaging, labelling, documentation, disposal and contingency procedures, where appropriate.
(k) predlagane metode za varno shranjevanje, prevoz in uporabo živih spremenjenih organizmov ter ravnanje z njimi skupaj s pakiranjem, označevanjem, dokumentiranjem, odstranjevanjem in postopki za ravnanje v posebnih razmerah, če je to primerno.
The objective of risk assessment, under this Protocol, is to identify and evaluate the potential adverse effects of living modified organisms on the conservation and sustainable use of biological diversity in the likely potential receiving environment, taking also into account risks to human health.
Po tem protokolu je cilj izdelave ocene tveganja na podlagi analize opredeliti in ovrednotiti možne škodljive vplive živih spremenjenih organizmov na ohranjanje in trajnostno uporabo biološke raznovrstnosti v okolju, ki bo verjetno prejelo te organizme, pri čemer je treba upoštevati tveganje za zdravje ljudi.
Use of risk assessment
Uporaba ocene tveganja
Risk assessment is, inter alia, used by competent authorities to make informed decisions regarding living modified organisms.
Oceno tveganja med drugim uporabljajo pristojni organi za odločanje o živih spremenjenih organizmih na podlagi prejetih informacij.
Risk assessment should be carried out in a scientifically sound and transparent manner, and can take into account expert advice of, and guidelines developed by, relevant international organizations.
Ocena tveganja mora biti izdelana na znanstveno dobro premišljen in pregleden način, pri čemer se lahko upoštevajo strokovni nasveti ustreznih mednarodnih organizacij in smernice, ki so jih te organizacije pripravile.
Lack of scientific knowledge or scientific consensus should not necessarily be interpreted as indicating a particular level of risk, an absence of risk, or an acceptable risk.
Pomanjkanje znanstvenih dognanj ali nesoglasje znanstvenikov ne kaže nujno določene ravni tveganja, odsotnosti tveganja ali sprejemljivega tveganja.
Risks associated with living modified organisms or products thereof, namely, processed materials that are of living modified organism origin, containing detectable novel combinations of replicable genetic material obtained through the use of modern biotechnology, should be considered in the context of the risks posed by the non-modified recipients or parental organisms in the likely potential receiving environment.
Tveganja, povezana z živimi spremenjenimi organizmi ali izdelki iz njih (predelani material, ki izvira iz živih spremenjenih organizmov), ki vsebujejo zaznavne nove kombinacije genskega materiala, ki se lahko podvaja in je bil pridobljen z uporabo sodobne biotehnologije, je treba obravnavati z vidika tveganj, ki jih predstavljajo nespremenjeni prejemni ali starševski organizmi v okolju, ki bo verjetno prejelo spremenjene organizme.
Risk assessment should be carried out on a case-by-case basis.
Ocena tveganja se izdela za vsak primer posebej.
The required information may vary in nature and level of detail from case to case, depending on the living modified organism concerned, its intended use and the likely potential receiving environment.
Potrebne informacije se lahko od primera do primera razlikujejo v naravi in podrobnostih, odvisno od posameznega živega spremenjenega organizma, namena njegove uporabe in okolja, ki bo verjetno prejelo tak organizem.
The process of risk assessment may on the one hand give rise to a need for further information about specific subjects, which may be identified and requested during the assessment process, while on the other hand information on other subjects may not be relevant in some instances.
Na eni strani postopek izdelave ocene tveganja lahko vzbudi potrebo po nadaljnjih informacijah o posebnih temah, lahko pa se izkaže, da v nekaterih primerih informacije o drugih temah niso pomembne.
To fulfil its objective, risk assessment entails, as appropriate, the following steps
Da bi izdelava ocene tveganja izpolnila svoje cilje, po potrebi vključuje te stopnje
(a) An identification of any novel genotypic and phenotypic characteristics associated with the living modified organism that may have adverse effects on biological diversity in the likely potential receiving environment, taking also into account risks to human health;
(a) določitev kakršnih koli novih genotipskih in fenotipskih značilnosti, povezanih z živim spremenjenim organizmom, ki bi lahko škodljivo vplivale na biološko raznovrstnost v okolju, ki bo verjetno prejelo take organizme, pri čemer je treba upoštevati tudi tveganje za zdravje ljudi;
(b) An evaluation of the likelihood of these adverse effects being realized, taking into account the level and kind of exposure of the likely potential receiving environment to the living modified organism;
(b) ovrednotenje verjetnosti nastanka takih škodljivih vplivov ob upoštevanju ravni in vrste izpostavljenosti okolja, ki bo verjetno prejelo živ spremenjen organizem, temu organizmu;
(c) An evaluation of the consequences should these adverse effects be realized;
(c) ovrednotenje posledic, če taki škodljivi vplivi res nastanejo;
(d) An estimation of the overall risk posed by the living modified organism based on the evaluation of the likelihood and consequences of the identified adverse effects being realized;
(d) ovrednotenje celotnega tveganja, ki ga predstavlja živ spremenjen organizem, temelječe na presoji tveganja in posledic nastanka opredeljenih škodljivih vplivov;
(e) A recommendation as to whether or not the risks are acceptable or manageable, including, where necessary, identification of strategies to manage these risks; and
(e) priporočilo o tem, ali so tveganja sprejemljiva ali obvladljiva, skupaj z opredelitvijo strategij za obvladovanje teh tveganj, kadar je to potrebno;
(f) Where there is uncertainty regarding the level of risk, it may be addressed by requesting further information on the specific issues of concern or by implementing appropriate risk management strategies and/or monitoring the living modified organism in the receiving environment.
(f) če ni mogoče zanesljivo določiti ravni tveganja, se lahko zahtevajo dodatne informacije o posebnih vprašanjih v zvezi z zadevo ali pa se izvedejo ustrezne strategije obvladovanja tveganja in/ali se spremlja in nadzoruje živ spremenjen organizem v prejemnem okolju.
Points to consider
Dejstva, ki jih je treba upoštevati
Depending on the case, risk assessment takes into account the relevant technical and scientific details regarding the characteristics of the following subjects
Pri oceni tveganja se, odvisno od primera, upoštevajo ustrezni tehnični in znanstveni podatki o značilnostih teh dejavnikov
(a) Recipient organism or parental organisms.
(a) prejemni ali starševski organizmi.
The biological characteristics of the recipient organism or parental organisms, including information on taxonomic status, common name, origin, centres of origin and centres of genetic diversity, if known, and a description of the habitat where the organisms may persist or proliferate;
Biološke značilnosti prejemnega ali starševskih organizmov skupaj z informacijami o sistematski uvrstitvi, domačem imenu, izvoru, središčih izvora in središčih genske raznovrstnosti, če so ta znana, in opisom habitata, v katerem bi organizmi lahko obstali ali se razmnoževali;
(b) Donor organism or organisms.
(b) organizem ali organizmi dajalci.
Taxonomic status and common name, source, and the relevant biological characteristics of the donor organisms;
Sistematska uvrstitev in domače ime, vir in ustrezne biološke značilnosti organizmov dajalcev;
Characteristics of the vector, including its identity, if any, and its source or origin, and its host range;
Značilnosti vektorja z njegovo identiteto vred, če je znana, njegovim virom ali izvorom in spektrom gostiteljev;
(d) Insert or inserts and/or characteristics of modification.
(d) vnesen material in/ali značilnosti spremembe.
Genetic characteristics of the inserted nucleic acid and the function it specifies, and/or characteristics of the modification introduced;
Genske značilnosti vnesene nukleinske kisline in funkcija, ki jo določa, in/ali značilnosti vnesene spremembe;
(e) Living modified organism.
(e) živ spremenjen organizem.
Identity of the living modified organism, and the differences between the biological characteristics of the living modified organism and those of the recipient organism or parental organisms;
Identiteta živega spremenjenega organizma in razlike med biološkimi značilnostmi živega spremenjenega organizma in značilnostmi prejemnega ali starševskih organizmov;
(f) Detection and identification of the living modified organism.
(f) odkrivanje in prepoznavanje živega spremenjenega organizma.
Suggested detection and identification methods and their specificity, sensitivity and reliability;
Predlagane metode za odkrivanje in prepoznavanje ter njihova posebnost, občutljivost in zanesljivost;
(g) Information relating to the intended use.
(g) informacije v zvezi z namenom uporabe.
Information relating to the intended use of the living modified organism, including new or changed use compared to the recipient organism or parental organisms; and
Informacije v zvezi z namenom uporabe živega spremenjenega organizma skupaj z novo ali spremenjeno uporabo v primerjavi s prejemnim ali starševskimi organizmi;
(h) Receiving environment.
(h) prejemno okolje.
Information on the location, geographical, climatic and ecological characteristics, including relevant information on biological diversity and centres of origin of the likely potential receiving environment.
Informacije o lokacijskih, geografskih, podnebnih in ekoloških značilnostih skupaj z ustreznimi informacijami o biološki raznovrstnosti in središčih izvora okolja, ki bo verjetno prejelo spremenjeni organizem.
Agreement Between the Government of the Republic of Slovenia and the Government of the State of Kuwait on the Promotion and Reciprocal Protection of Investments
Sporazum med Vlado Republike Slovenije in Vlado Države Kuvajt o spodbujanju in medsebojni zaščiti naložb
The Government of the Republic of Slovenia and the Government of the State of Kuwait, hereinafter referred to as the “Contracting Parties”
Vlada Republike Slovenije in Vlada Države Kuvajt, v nadaljevanju pogodbenici, sta se
Desiring to intensify the economic co-operation between the two Contracting Parties
v želji, da okrepita gospodarsko sodelovanje med pogodbenicama
Recognising that the promotion and reciprocal protection of investments on the basis of this Agreement will stimulate business initiative
ob spoznanju, da bosta spodbujanje in medsebojna zaščita naložb na podlagi tega sporazuma spodbujala poslovne pobude
The term “investment” shall mean every kind of assets or rights owned or controlled directly or indirectly by investors of one Contracting Party in the territory of the other Contracting Party in accordance with the laws and regulations of the latter including, in particular, though not exclusively
Izraz “naložba“ pomeni vsako vrsto premoženja ali pravic v lasti ali pod neposrednim ali posrednim nadzorom vlagateljev ene pogodbenice na ozemlju druge pogodbenice v skladu z zakoni in predpisi druge pogodbenice in vključuje zlasti, vendar ne izključno
(a) tangible and intangible and movable and immovable property and any other related property rights, such as mortgages, liens, pledges and similar rights;
a) opredmeteno in neopredmeteno premoženje ter premičnine in nepremičnine in katere koli druge s tem povezane stvarne pravice, kot so hipoteka, zaseg, zastava in podobne pravice;
(b) shares, stocks, bonds, debentures, any other form of participation in a company and loans;
b) deleže, delnice, obveznice, zadolžnice, katero koli drugo obliko udeležbe v družbi in posojila;
(c) claims to money or to any performance having an economic value and associated with an investment;
c) denarne terjatve ali katere koli storitve, ki imajo ekonomsko vrednost in so povezane z naložbo;
(d) intellectual property rights, including, but not limited to, copyrights, trademarks, patents, industrial designs and patterns and technical processes, know-how, trade secrets, trade names and goodwill;
d) pravice intelektualne lastnine, vključno z avtorskimi pravicami, vendar ne omejeno nanje, blagovne znamke, patente, industrijske modele in vzorce, tehnične postopke, know-how, poslovne skrivnosti, imena firm in dobro ime;
(e) rights conferred by law, either under a contract or an administrative act, by a competent state authority including concessions for prospecting, exploration and exploitation of natural resources.
e) pravice, vključno s koncesijami za iskanje, raziskovanje in izkoriščanje naravnih virov, ki jih z zakonom bodisi po pogodbi ali upravnem aktu podeljuje pristojni državni organ.
The term “investment” shall also apply to “returns” retained for the purpose of re-investment and to proceeds from “liquidation”.
Izraz “naložba“ se uporablja tudi za “dohodek“, zadržan za reinvestiranje, in za izkupiček od “likvidacije“.
Any alteration of the form in which assets or rights are invested or reinvested shall not affect their character as investments, provided that such alteration is in accordance with the laws and regulations of the Contracting Party in whose territory the investment has been made.
Kakršna koli sprememba oblike, v kateri se premoženje ali pravice investirajo ali reinvestirajo, ne vpliva na njihovo naravo kot naložbo pod pogojem, da je taka sprememba v skladu z zakoni in predpisi pogodbenice, na katere ozemlju je bila naložba izvedena.
The term “returns” shall mean the amounts yielded by investments and in particular, though not exclusively, shall include profits, capital gains, dividends, interests, royalties or other forms of income related to the investments, managements fees and payments in kind.
Izraz “dohodek“ pomeni zneske, ki jih prinašajo naložbe, in vključuje zlasti, vendar ne izključno, dobiček, kapitalski dobiček, dividende, obresti, licenčnine ali druge oblike dohodka, povezanega z naložbami, izplačili za poslovodstvo in plačili v naravi.
The term “investor” shall mean
Izraz “vlagatelj“ pomeni
(a) natural persons having the nationality of either Contracting Party, in accordance with its applicable laws
a) fizične osebe, ki so državljani ene ali druge pogodbenice v skladu z njeno ustrezno zakonodajo
(b) any legal person constituted or incorporated under the laws and regulations of that Contracting Party, such as institutions, development funds, agencies, foundations, authorities, and companies
b) katero koli pravno osebo, ustanovljeno ali registrirano po zakonih in predpisih te pogodbenice, kot so institucije, razvojni skladi, agencije, fundacije, organi in družbe
(c) legal persons not established or constituted under the law of a Contracting Party
c) pravne osebe, ki niso ustanovljene ali registrirane po pravu pogodbenice
(1) in which more than 50 per cent of the equity interest is beneficially owned by persons of that Contracting Party;
(1) v katerih so osebe te pogodbenice upravičene uresničevati nad 50 odstotkov pravic iz kapitalske udeležbe;
(2) in relation to which persons of that Contracting Party have the power to name a majority of its directors or otherwise legally direct its actions.
(2) v zvezi s katerimi so osebe te pogodbenice pooblaščene, da imenujejo večino njihovih direktorjev ali drugače pravno usmerjajo njihova dejanja;
(d) the Government of that Contracting Party.
d) vlado te pogodbenice.
The term “national territory“ means
Izraz “ozemlje“ pomeni
(a) with respect to the Republic of Slovenia the territory under its sovereignty, including air space and maritime areas, over which the Republic of Slovenia exercises its sovereignty or jurisdiction, in accordance with internal and international law;
a) za Republiko Slovenijo ozemlje pod njeno suverenostjo, vključno z zračnim prostorom in morskimi območji, nad katerimi Republika Slovenija izvaja suverenost ali jurisdikcijo v skladu z notranjim in mednarodnim pravom;
(b) with respect to the State of Kuwait the territory of the State of Kuwait including any area beyond the territorial sea which in accordance with international law has been or may hereafter be designated under the laws of the State of Kuwait, as an area over which the State of Kuwait may exercise sovereign rights or jurisdiction.
b) za Državo Kuvajt ozemlje Države Kuvajt, vključno z katerim koli območjem zunaj teritorialnega morja, ki je bilo v skladu z mednarodnim pravom določeno ali se še lahko določi po zakonih Države Kuvajt za območje, nad katerim lahko Država Kuvajt izvaja suverene pravice ali jurisdikcijo.
The term “freely convertible currency” shall mean any currency that the International Monetary Fund determines, from time to time, as freely usable currency in accordance with the Articles of Agreement of the International Monetary Fund and any amendment thereto.
Izraz “prosto zamenljiva valuta“ pomeni katero koli valuto, ki jo Mednarodni denarni sklad občasno določi za prosto uporabljivo valuto v skladu s Statutom Mednarodnega denarnega sklada in vsemi njegovimi spremembami ali dopolnitvami.
The term “without delay” shall mean such period as is normally required for the completion of necessary formalities for the transfer of payments.
Izraz “brez odlašanja“ pomeni tako obdobje, kot je običajno potrebno za dokončanje potrebnih formalnosti za prenos plačil.
The said period shall commence on the day on which the request for transfer has been submitted and may on no account exceed one month.
Omenjeno obdobje se začne na dan, ko je bil predložen zahtevek za prenos, in v nobenem primeru ne sme presegati enega meseca.
Promotion of Investments
Spodbujanje naložb